Capricor Therapeutics, Inc.
NASDAQ:CAPR · NASDAQ Global Select
-$0.14 today
Vol 3.06M · Avg 1.08M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+269.53%
Period High
$35.34
Period Low
$4.60
Latest
$28.38
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Achieve Life Sciences, Inc.
NASDAQ:ACHV
$503.54M
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$481.64M
Cabaletta Bio, Inc.
NASDAQ:CABA
$468.78M
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
$389.86M
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
$345.48M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$263.20M
Editas Medicine, Inc.
NASDAQ:EDIT
$252.09M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$210.47M
ProQR Therapeutics N.V.
NASDAQ:PRQR
$190.70M
Immutep Limited
NASDAQ:IMMP
$55.49M
What is the latest CAPR filing?
The latest filing shown is 8-K dated Jun 8, 2026.
How many recent filings does CAPR have?
Intrinsic Alpha currently shows 20 recent filings for CAPR.
Explore More
Continue the stock analysis
Jump to another research area for this company.